Marsh & McLennan Companies, Inc. (MRSH)
| Market Cap | 94.76B +1.8% |
| Revenue (ttm) | 28.46B +7.6% |
| Net Income | 4.04B -2.1% |
| EPS | 8.35 +0.1% |
| Shares Out | 475.51M |
| PE Ratio | 23.87 |
| Forward PE | 17.76 |
| Dividend | $3.96 (1.99%) |
| Ex-Dividend Date | Oct 1, 2026 |
| Volume | 3,065,201 |
| Open | 192.00 |
| Previous Close | 190.56 |
| Day's Range | 191.64 - 199.59 |
| 52-Week Range | 156.60 - 199.59 |
| Beta | 0.58 |
| Analysts | Hold |
| Price Target | 204.52 (+2.64%) |
| Earnings Date | Oct 15, 2026 |
About MRSH
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking... [Read more]
Financial Performance
In 2025, MRSH's revenue was $26.98 billion, an increase of 10.32% compared to the previous year's $24.46 billion. Earnings were $4.16 billion, an increase of 2.46%.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for MRSH stock is "Hold." The 12-month stock price target is $204.52, which is an increase of 2.64% from the latest price.
News
Marsh Announces Pricing of €1.2 Billion Senior Notes Offering
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH) (the “Company”) announced today that it has priced €600 million aggregate principal amount of its 4.250% Senior Notes due 2032 and €600 million aggregate ...
Aging Populations Are Straining Retirement Systems Worldwide, According to the 2026 Marsh CFA Institute Global Pension Index
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a leading global professional services firm, and CFA Institute, the global association of investment professionals, today released the 18th annual Marsh ...
Marsh McLennan price target raised to $218 from $215 at JPMorgan
JPMorgan analyst Pablo Singzon raised the firm’s price target on Marsh McLennan (MRSH) to $218 from $215 and keeps an Overweight rating on the shares. The firm upped the company’s…
Marsh McLennan price target raised to $200 from $190 at Mizuho
Mizuho raised the firm’s price target on Marsh McLennan (MRSH) to $200 from $190 and keeps a Neutral rating on the shares.
Marsh McLennan price target raised to $201 from $186 at Keefe Bruyette
Keefe Bruyette analyst Meyer Shields raised the firm’s price target on Marsh McLennan (MRSH) to $201 from $186 and keeps a Market Perform rating on the shares following the Q3…
Marsh McLennan price target raised to $190 from $180 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Marsh McLennan (MRSH) to $190 from $180 and keeps an Equal Weight rating on the shares. The firm updated its model to…
Marsh McLennan price target raised to $197 from $183 at Wells Fargo
Wells Fargo raised the firm’s price target on Marsh McLennan (MRSH) to $197 from $183 and keeps an Equal Weight rating on the shares. The firm notes shares traded higher,…
Marsh McLennan price target raised to $180 from $177 at BofA
BofA raised the firm’s price target on Marsh McLennan (MRSH) to $180 from $177 and keeps an Underperform rating on the shares. The firm applies a slightly higher multiple to…
Marsh McLennan price target raised to $203 from $200 at Citi
Citi analyst Matthew Heimermann raised the firm’s price target on Marsh McLennan (MRSH) to $203 from $200 and keeps a Neutral rating on the shares.
Marsh & McLennan Companies Earnings Call Transcript: Q3 2026
Q3 revenue grew 8% to $6.9B, underlying growth was 5%, and adjusted EPS rose 10% to $2.03. FY26 guidance calls for underlying growth similar to 2025, margin expansion and a higher $600M Thrive savings target.
Marsh & McLennan Companies Earnings release: Q3 2026
Marsh & McLennan Companies released its Q3 2026 earnings on October 15, 2026, summarizing the period's financial results.
Marsh & McLennan Companies Quarterly report: Q3 2026
Marsh & McLennan Companies has published its Q3 2026 quarterly earnings report on October 15, 2026.
Marsh & McLennan Companies Slides: Q3 2026
Marsh & McLennan Companies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 15, 2026.
Marsh Reports Third Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the third quart...
Marsh and Bloomberg New Economy Launch Coalition to Strengthen Resilience and Drive Growth in a Turbulent World
NEW DELHI & NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a leading global professional services firm, and Bloomberg New Economy today announced the launch of their Competitive Resilience Coalition, ...
Marsh McLennan price target lowered to $177 from $182 at BofA
BofA lowered the firm’s price target on Marsh McLennan (MRSH) to $177 from $182 and keeps an Underperform rating on the shares. The firm, which adjusted estimates and targets among…
Marsh McLennan price target lowered to $183 from $188 at Wells Fargo
Wells Fargo lowered the firm’s price target on Marsh McLennan (MRSH) to $183 from $188 and keeps an Equal Weight rating on the shares. Given weaker performance from brokers, the…
Marsh McLennan price target lowered to $186 from $202 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Marsh McLennan (MRSH) to $186 from $202 and keeps a Market Perform rating on the shares.
Marsh McLennan price target lowered to $190 from $201 at Mizuho
Mizuho lowered the firm’s price target on Marsh McLennan (MRSH) to $190 from $201 and keeps a Neutral rating on the shares. The firm adjusted targets in the insurance group…
Marsh McLennan price target lowered to $180 from $200 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Marsh McLennan (MRSH) to $180 from $200 and keeps an Equal Weight rating on the shares. The firm is adjusting targets for…
Marsh McLennan price target raised to $222 from $216 at UBS
UBS raised the firm’s price target on Marsh McLennan (MRSH) to $222 from $216 and keeps a Buy rating on the shares.
Marsh Completes Acquisition of Accel Holdings
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE:MRSH), a leading global professional services firm, today announced the completion of its previously announced agreement to acquire Accel Holdings, Inc, a leadin...
Marsh McLennan price target raised to $215 from $212 at JPMorgan
JPMorgan raised the firm’s price target on Marsh McLennan (MRSH) to $215 from $212 and keeps an Overweight rating on the shares. The firm adjusted ratings and target in the…
Archer by Marsh Launches to Help Life and Annuity Insurers and Asset Managers Build and Operate Reinsurance Businesses
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global professional services firm, today announced the launch of Archer by Marsh, a service that helps asset managers and life and annuity insurers est...
Marsh Appoints Birgit Boykin Chief People Officer of Oliver Wyman and Marsh Management Consulting
NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a Marsh business (NYSE:MRSH), today announced the appointment of Birgit Boykin as Chief People Officer of Oliver W...